CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to KALV

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Q3 '27
KALVPhase 3

KVD900 600 mg Phase 3 Est. Readout

KVD900 600 mg
Q3 2027~QSTALE
CT.gov
00%
Competitive Landscape

1 competitor in Hereditary Angioedema

View Full Landscape
Drug Information

Target Indication

Hereditary Angioedema

Clinical Trial

NCT05511922

Last updated: 1/2/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.